# Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel

> **NCT04452643** · PHASE3 · WITHDRAWN · sponsor: **Inmunotek S.L.**

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** BACMUNE (MV130)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04452643
- **Lead sponsor:** Inmunotek S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not authorized by Cofepris (Mexico Competent Regulatory Authority)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04452643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04452643, "Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04452643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*